Amifampridine
ATC N07XX05 · 5 markets · 14 records
GB 6 records · 2 strengths
- 10 mgtablet3,4-Diaminopyridine 20mg tabletsFirdapse、Manufacturer: Lupin Healthcare (UK) Ltd、Manufacturer: Special Order
- 20 mgtablet3,4-Diaminopyridine 20mg tabletsManufacturer: Special Order
AU 3 records · 2 strengths
- 10 mgtabletRuzurgiRUZURGI amifampridine 10 mg tablet bottle
Records without a stated strength · 1 Ruzurgi
CA 2 records · 1 strengths
- 10 mgtabletFirdapseRuzurgi
EU 2 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Amifampridine SERB、Firdapse
US 1 records · 1 strengths
- 10 mgtabletFirdapse
| Strength / form / release | US | GB | CA | AU | EU |
|---|---|---|---|---|---|
| 10 mg tablet | Firdapse | 3,4-Diaminopyridine 20mg tablets Manufacturer: Lupin Healthcare (UK) Ltd Manufacturer: Special Order ×2+1Firdapse | Firdapse Ruzurgi | Ruzurgi RUZURGI amifampridine 10 mg tablet bottle | |
| 20 mg tablet | 3,4-Diaminopyridine 20mg tablets Manufacturer: Special Order ×2 | ||||
unknown | Ruzurgi | Amifampridine SERB Firdapse |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.